ArticleCancer2025
Health literacy and all-cause mortality among cancer patients.
Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Advancing Patient-Centred AI With Adaptive Machine Learning.Cancer medicine · 2026Review
- Artificial intelligence-powered chatbots for oral anticancer drug patient information: an assessment of quality.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Evaluating the role of survivorship care plans in modifying disparities in health status among female cancer survivors in Maryland.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Social Determinants of Health in Metastatic Breast Cancer Care: A Podcast Exploring Challenges and Opportunities in the United States and Canada.Oncology and therapy · 2026Article
- The Use of ChatGPT-4.0 to Simplify Breast Pathology Reports: A Study on Readability and Accuracy.Annals of surgical oncology · 2025Article
- Article
- Evaluating A Patient-Led Health Literacy Program for People Living With Metastatic Breast Cancer.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between health literacy and all-cause mortality among cancer patients remains unclear.
methodsThis is a retrospective cohort study of 9603 patients diagnosed with prostate, lung, breast, renal, colorectal, brain, head and neck, bladder, pancreatic, liver, sarcoma, and gastric cancers who were screened for health literacy between 2008 and 2018, using the Brief Health Literacy Screen (BHLS). Higher scores (range, 3-15) indicate higher health literacy. The association between all-cause mortality and health literacy was estimated using multivariable Cox proportional hazards models.
resultsA total of 8608 (89%) patients were non-Hispanic White. The median follow-up was 3.1 years. Patients with a BHLS score of 15 had a median survival improvement of 9.4 months (95% confidence interval [CI], 6.0-13.2 months) compared to those with a score of 9. Lower BHLS scores (9 vs. 15) were associated with higher mortality in stages II (adjusted hazard ratio [aHR], 2.6 [95% CI, 1.5-5.1]) and III (aHR 2.9 [95% CI, 1.4-6.0]) prostate cancer; stages I (aHR 1.7 [95% CI, 1.1-2.5]) and IV (aHR, 1.6 [95% CI, 1.2-2.1]) lung cancer; stage I colorectal cancer (aHR, 2.2 [95% CI, 1.3-4.7]); stage I renal cancer (aHR, 1.8 [95% CI, 1.1-3.4]); stages I (aHR, 2.6 [95% CI, 1.3-7.1]) and IV (aHR, 1.7 [95% CI, 1.2-2.7]) head and neck cancer; stage II bladder cancer (aHR, 1.6 [95% CI, 1.0-2.8]); stage I liver cancer (aHR, 4.1 [95% CI, 1.9-9.3]); and all stages of breast cancer.
conclusionsLower health literacy was associated with higher all-cause mortality among patients with 12 different types of cancer, varying by cancer type and stage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.